retatrutide developer company Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide (LY-3437943) Market Analysis, 2033:

In clinical studies targeting obesity, particularly in the phase 3 trials based on the SURPASS program, tirzepatide demonstrated outstanding weight reduction benefits, with some patients achieving a weight loss of up to 22.5%

At the forefront of this movement is TRT Nation, a telehealth clinic committed to personalized, medically supervised care that removes barriers between patients and the results they deserve

GLP-1s can be incredibly beneficial in the right patient and potentially problematic in the wrong patient, according to Dr

Is it safe to drink alcohol while using GLP-1 drops

This stage is created to support your ongoing healthy habits and long-term wellness goals

Foods like cucumbers, watermelon, strawberries, soups, and broths contribute to your daily fluid intake